These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16708912)

  • 1. [Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
    Hanamura A; Hayakawa M; Naito K
    Rinsho Ketsueki; 2005 Jan; 46(1):13-8. PubMed ID: 16708912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disappearance of CD 20 after treatment with rituximab of mantle cell lymphoma].
    Yoshida K; Kayano H; Shimada T; Wakao D; Takahashi N; Sugahara Y; Yagasaki F; Ito Y; Kawai N; Matsuda A; Suzuki T; Bessho M
    Rinsho Ketsueki; 2003 Mar; 44(3):174-81. PubMed ID: 12722344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)].
    Ando S; Ando S; Otani N; Kanbe T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):153-6. PubMed ID: 8422181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].
    Muraoka A; Asami M; Ueno H; Yoneda R; Ogura M; Oribe T; Suzuki K; Maeda M; Chinzei T; Yamashiro K
    Rinsho Ketsueki; 1990 Nov; 31(11):1840-4. PubMed ID: 2287070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary subcutaneous mantle cell lymphoma treated successfully with THP-COP therapy].
    Hisatake J; Kawakami K; Nakamaki T; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2002 May; 43(5):384-8. PubMed ID: 12096492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mantle cell lymphoma markedly infiltrated into adrenal glands with adrenal insufficiency].
    Hashimoto R; Iwakiri R; Tsutsumi H; Ohta M; Mori M
    Rinsho Ketsueki; 2004 Jul; 45(7):551-6. PubMed ID: 15359915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal infiltrate by a plasmocytoïd chronic B lymphocytic leukaemia and renal failure: a rare occurrence in nephropathology. A case report and review of the literature].
    Aymard B; Beghoura R; Molina TJ
    Nephrol Ther; 2011 Nov; 7(6):479-87. PubMed ID: 21439927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular conjunctivitis caused by a mantle cell lymphoma.
    Amstutz CA; Michel S; Thiel MA
    Klin Monbl Augenheilkd; 2004 May; 221(5):398-400. PubMed ID: 15162290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
    Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA
    J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
    Ogura M
    Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
    Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
    J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma.
    Orciuolo E; Buda G; Pelosini M; Petrini M
    Br J Haematol; 2010 Mar; 148(5):810-2. PubMed ID: 19919649
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
    Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
    Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
    Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
    Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
    Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
    Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A
    Oncology; 2006; 70(6):411-7. PubMed ID: 17220639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
    Garcia M; Romaguera JE; Inamdar KV; Rassidakis GZ; Medeiros LJ
    Cancer; 2009 Mar; 115(5):1041-8. PubMed ID: 19170236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.